| scholarly article | Q13442814 |
| P50 | author | Alexander Tropsha | Q4720252 |
| P2093 | author name string | Hao Tang | |
| Xiang Simon Wang | |||
| Jui-Hua Hsieh | |||
| P2860 | cites work | DrugBank: a comprehensive resource for in silico drug discovery and exploration | Q24188653 |
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| The Protein Data Bank | Q24515306 | ||
| Structure of a nanobody-stabilized active state of the β(2) adrenoceptor | Q24597139 | ||
| Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists | Q24619974 | ||
| Structure and function of an irreversible agonist-β(2) adrenoceptor complex | Q24620291 | ||
| The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist | Q24654563 | ||
| High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor | Q24657484 | ||
| Structure modeling of all identified G protein-coupled receptors in the human genome | Q25256886 | ||
| GLIDA: GPCR-ligand database for chemical genomic drug discovery | Q25257715 | ||
| MODBASE: a database of annotated comparative protein structure models and associated resources | Q25257904 | ||
| Crystal structure of rhodopsin: A G protein-coupled receptor | Q27625972 | ||
| Crystal structure of the human beta2 adrenergic G-protein-coupled receptor | Q27648868 | ||
| A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor | Q27650801 | ||
| Crystal structure of the ligand-free G-protein-coupled receptor opsin | Q27650885 | ||
| Structure of a beta1-adrenergic G-protein-coupled receptor | Q27651011 | ||
| WHAT IF: a molecular modeling and drug design program | Q27860734 | ||
| A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases | Q28140411 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 | ||
| eHiTS: a new fast, exhaustive flexible ligand docking system | Q28253448 | ||
| GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function | Q28254935 | ||
| A semiempirical free energy force field with charge-based desolvation | Q29614316 | ||
| Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure. | Q30376612 | ||
| GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex | Q30437388 | ||
| Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes | Q30437514 | ||
| Drug design strategies for targeting G-protein-coupled receptors | Q30859422 | ||
| NIH Molecular Libraries Initiative | Q31127242 | ||
| GPCR structure-based virtual screening approach for CB2 antagonist search | Q33288322 | ||
| Molecular docking screens using comparative models of proteins | Q33511631 | ||
| Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes | Q34333541 | ||
| Opsin is present as dimers in COS1 cells: identification of amino acids at the dimeric interface | Q34480194 | ||
| Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models. | Q34561020 | ||
| Dynamic behavior of fully solvated beta2-adrenergic receptor, embedded in the membrane with bound agonist or antagonist. | Q34596611 | ||
| Predicting the accuracy of protein-ligand docking on homology models. | Q34669773 | ||
| Modeling the 3D structure of GPCRs: advances and application to drug discovery | Q35166029 | ||
| Optimising the use of beta-adrenoceptor antagonists in coronary artery disease | Q36093271 | ||
| Computational modeling approaches to structure-function analysis of G protein-coupled receptors | Q36256115 | ||
| On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor. | Q36744266 | ||
| Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists | Q36852012 | ||
| Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008. | Q37309553 | ||
| G protein-coupled receptors: in silico drug discovery in 3D. | Q37388375 | ||
| Development of quantitative structure-binding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces | Q37412416 | ||
| Screening drug-like compounds by docking to homology models: a systematic study. | Q40356909 | ||
| Molecular modeling of the binding of pheromone biosynthesis activating neuropeptide to its receptor | Q42033264 | ||
| Chemometric analysis of ligand receptor complementarity: identifying Complementary Ligands Based on Receptor Information (CoLiBRI). | Q42574841 | ||
| Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes | Q42602259 | ||
| Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment | Q42863821 | ||
| Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? | Q44242205 | ||
| Three-Dimensional Models for β-Adrenergic Receptor Complexes with Agonists and Antagonists | Q44604131 | ||
| Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model | Q45104890 | ||
| 2D depiction of protein-ligand complexes. | Q51907376 | ||
| Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem. | Q51922697 | ||
| Managing bias in ROC curves. | Q53033714 | ||
| Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
| Three-dimensional models for agonist and antagonist complexes with beta 2 adrenergic receptor | Q71730308 | ||
| Three-dimensional representations of G protein-coupled receptor structures and mechanisms | Q74818940 | ||
| A crystal clear view of the beta2-adrenergic receptor | Q80657778 | ||
| Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor | Q81409742 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| crystal structure | Q895901 | ||
| P304 | page(s) | 1503-1521 | |
| P577 | publication date | 2012-03-13 | |
| P1433 | published in | Proteins | Q7251514 |
| P1476 | title | Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening? | |
| P478 | volume | 80 |
| Q30392142 | Beyond Membrane Protein Structure: Drug Discovery, Dynamics and Difficulties |
| Q34647300 | Development of 7TM receptor-ligand complex models using ligand-biased, semi-empirical helix-bundle repacking in torsion space: application to the agonist interaction of the human dopamine D2 receptor |
| Q38976083 | Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models. |
| Q28818657 | GPCRs from fusarium graminearum detection, modeling and virtual screening - the search for new routes to control head blight disease |
| Q38390892 | Improvements, trends, and new ideas in molecular docking: 2012-2013 in review. |
| Q38092807 | Latest developments in molecular docking: 2010-2011 in review |
| Q30355473 | Modelling three-dimensional protein structures for applications in drug design. |
| Q33858991 | Molecular determinants of ligand binding at the human histamine H1 receptor: Site-directed mutagenesis results analyzed with ligand docking and molecular dynamics studies at H1 homology and crystal structure models |
| Q27902288 | Multiple conformational states in retrospective virtual screening – homology models vs. crystal structures: beta-2 adrenergic receptor case study |
| Q30366789 | Protein structure prediction provides comparable performance to crystallographic structures in docking-based virtual screening. |
Search more.